Skip to main content

Creating Hope Act of 2011


November 30, 2016
With the passage of the 21st Century Cures Bill in the U.S. House, cancer research received a major boost while critical childhood cancer provisions have passed while others were extended.

July 10, 2015
The House passed the 21st Century Cures Act to increase funding for the National Institutes of Health (NIH) and reauthorize the Creating Hope Act which will incentivize the development of new treatments for children with rare pediatric diseases, such as cancer.

March 13, 2015
The sponsors of the Creating Hope Act applaud the approval of the first drug ever to treat high-risk neuroblastoma and call for the law to be made permanent.

September 19, 2013
Progress into research and development of the first new pediatric cancer drugs in nearly 30 years was announced at the 4th Annual Congressional Childhood Cancer Summit on Capitol Hill on September 19, 2013.

July 9, 2012

President Signs McCaul-Butter


July 9, 2012
President Obama signed a bill today that will provide incentives to drug companies to research and develop drugs for rare diseases. The Creating Hope Act grants pharmaceutical companies that create drugs for diseases like childhood cancers a voucher giving speedier review of any other drug they submit for approval. The Oval Office signature was a hard-fought victory for children like Mollie Ward

July 9, 2012
Incentivizes Drug Companies to Develop New Treatments for Children with Rare Pediatric Diseases

July 5, 2012
WASHINGTON - When all else failed, the promise of corporate profits for pediatric cancer drugs did what cajoling to save children could not. Legislation by Texas Rep.